November 1, 2017 / 10:51 AM / in 19 days

BRIEF-Sucampo reports Q3 GAAP earnings per share $0.19

Nov 1 (Reuters) - Sucampo Pharmaceuticals Inc

* Sucampo reports third quarter 2017 financial results

* Q3 GAAP earnings per share $0.19

* Q3 revenue $61.3 million versus I/B/E/S view $58 million

* Q3 earnings per share view $0.25 -- Thomson Reuters I/B/E/S

* Sees FY 2017 adjusted earnings per share $1.10 to $1.15

* Q3 adjusted earnings per share $0.27

* Sucampo Pharmaceuticals Inc - For FY17 ‍sucampo now expects total revenue of $250.0 million to $255.0 million​

* Q3 earnings per share view $0.25, revenue view $58.0 million -- Thomson Reuters I/B/E/S

* Sucampo Pharmaceuticals Inc - Sees FY 2017 ‍free cash flow of $99.0 million to $104.0 million​

* Sucampo Pharmaceuticals - ‍Increases 2017 guidance for all key financial metrics based on “stronger than expected” sales of Amitiza in U.S. & Japan

* FY2017 earnings per share view $1.01, revenue view $234.5 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below